Mu-opioid receptor-positive neurons in rostral ventromedial medulla drive pain sensitization after traumatic brain injury in both male and female mice
Abstract Persistent headache and pain hypersensitivity are common after mild traumatic brain injury (mTBI). However, the central mechanisms that support posttraumatic pain sensitization are not fully understood. The rostral ventromedial medulla (RVM), a key output node of the endogenous pain modulation system, contains mu-opioid receptor-positive (Oprm+) pain-facilitating neurons that are important in chronic pain. Here, we investigated whether these neurons are essential for post-mTBI pain behaviors, vulnerability to persistent headache and postsurgical pain, and latent sensitization in mice. Male and female mice received dermorphin-saporin to lesion RVM Oprm+ neurons or blank-saporin as controls, then underwent mTBI or sham-TBI treatment. Periorbital and hindpaw mechanical sensitivity were measured. After recovery, vulnerability to persistent periorbital and hindpaw allodynia was assessed using bright-light stress (BLS) and hindpaw incision, respectively. Latent sensitization was assessed by administering naloxone 100 days post-mTBI. mTBI caused acute periorbital and hindpaw allodynia, unaffected by RVM Oprm+ neuron lesioning. However, lesioning of RVM Oprm+ neurons prevented reinstatement of periorbital and hindpaw allodynia after BLS, incision or naloxone, with effects conserved across sexes. RVM Oprm+ neurons support persistent post-mTBI pain sensitization. Their dysregulation after mTBI may increase an individual’s vulnerability to headache, persistent postsurgical pain, and latent pain sensitization.
Authors
- Peyman Sahbaie (ORCID: https://orcid.org/0000-0003-3319-8925)
- QiLiang Chen
- J. David Clark
- Karen-Amanda Irvine
Institutions
- VA Palo Alto Health Care System (US)
- Stanford University (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-09-30
- DOI
- https://doi.org/10.1038/s41598-026-70995-4
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00